NYR 11.1% 4.8¢ nyrada inc.

Ann: European Patent to be Granted for Cholesterol-Lowering Drug, page-10

  1. 101 Posts.
    lightbulb Created with Sketch. 8
    Main reason for the overselling is due to the China lockdowns impacting the company contracted to produce the drug. Not a fundamental sell down in any way, just market sentiment. At the current price this is a screaming buy.
 
watchlist Created with Sketch. Add NYR (ASX) to my watchlist
(20min delay)
Last
4.8¢
Change
-0.006(11.1%)
Mkt cap ! $8.746M
Open High Low Value Volume
5.4¢ 5.4¢ 4.8¢ $37.91K 752.8K

Buyers (Bids)

No. Vol. Price($)
1 194671 4.8¢
 

Sellers (Offers)

Price($) Vol. No.
4.9¢ 26700 1
View Market Depth
Last trade - 15.57pm 30/07/2024 (20 minute delay) ?
NYR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.